Outlook Therapeutics OTLK
$ 5.16
-2.27%
Quarterly report 2024-Q2
added 08-14-2024
Outlook Therapeutics EV/EBITDA Ratio 2011-2024 | OTLK
Annual EV/EBITDA Ratio Outlook Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-3.04 | -1.36 | -1.17 | -1.95 | -1.42 | -1.56 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-1.17 | -3.04 | -1.75 |